Fred D. Lublin, MD
In this special video presentation, Fred Lublin, MD discusses the impact of ocrelizumab on the growing MS treatment market. He also looks to the future of MS care and speaks about the challenges and opportunities of treatment selection.
Michelle Dougherty, MD, Peter Calabresi, MD
John Corboy, MD, Michelle Dougherty, MD, Robert T. Naismith, MD